SUNPHARMA:NSE
Sun Pharmaceutical Industries Ltd
1 758,80 ₹
arrow_downward
-0,29%(-5,20) 1D
16 հոկ, 15:30:00 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SUNPHARMA...
Open
1 762,20 ₹
High
1 764,90 ₹
Low
1 743,50 ₹
Mkt. cap
4,22 տրլն
Avg. vol.
1,45 մլն
Volume
1,52 մլն
Dividend
0,91%
Quarterly dividend
4,00 ₹
Ex-dividend date
07 հլս, 2026 թ.
P/E ratio
34,87
52-wk high
2 046,90 ₹
52-wk low
1 583,70 ₹
EPS
50,44 ₹
Shares outstanding
0,00
No. of employees
47 հզր
Open
1 762,20 ₹
High
1 764,90 ₹
Low
1 743,50 ₹
Mkt. cap
4,22 տրլն
Avg. vol.
1,45 մլն
Volume
1,52 մլն
Dividend
0,91%
Quarterly dividend
4,00 ₹
Ex-dividend date
07 հլս, 2026 թ.
P/E ratio
34,87
52-wk high
2 046,90 ₹
52-wk low
1 583,70 ₹
EPS
50,44 ₹
Shares outstanding
0,00
No. of employees
47 հզր
News stories
From web sources and news partners
ad-hoc-news.de
·
13 ժամ առաջ
Sun Pharma stock: Results are due October 29 for Sun Pharma stock
ad-hoc-news.de
·
19 ժամ առաջ
Crisil rates Sun Pharma debt AAA. Sun Pharma stock is valued at INR 4.2 trillion
ad-hoc-news.de
·
1 օր առաջ
Analyst consensus puts Sun Pharma stock at INR 2,180.00
Moneycontrol.com
·
3 օր առաջ
Sun Pharma: Tariff relief, innovation brighten growth outlook
Profile
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world.
Around 70% of Sun Pharma’s revenue is generated from international markets. The US and India are the largest markets, accounting for over 60% of the company's turnover. Manufacturing is across 43 locations in India, the US, Asia, Africa, Australia and Europe. The products cater to therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin. Wikipedia
About Sun Pharmaceutical Industries Ltd
CEO-
Employees47 հզր
Founded1983
HeadquartersGoregaon East, Մումբաի, Հնդկաստան
Sector-
Websitesunpharma.com